Sorin Brener is a Cardiology physician affiliated with Cardiovascular Research Foundation. OpenAlex indexes 365 publications with 9,883 citations (h-index 51). By OpenAlex citation count, this profile ranks in the top 10% of Interventional Cardiology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
506 6th St
Brooklyn, NY 112153609
Telephone
718-780-5143Provider last certified this registry record 16 Feb 2026.
Industry payments
15 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year202511 payments$12,875openpaymentsdata.cms.gov ↗
- Abbott LaboratoriesProgram year202414 payments$11,673openpaymentsdata.cms.gov ↗
- ABIOMEDProgram year20243 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
74.7%Beta blocker18.8%Metoprolol Succinate78%Carvedilol22%Part D<11 patientsAngiotensin receptor-neprilysin inhibitor (ARNI)14.6%Entresto100%Part D≥13 patients+ 5 more classes in this area
Blood & clotting
19.8%P2Y12 inhibitor14.3%Clopidogrel100%Part D≥16 patientsFactor Xa inhibitor5.5%Eliquis100%Part D<11 patientsMetabolism & gastrointestinal
5.5%Proton pump inhibitor5.5%Pantoprazole Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Prediction of Death or HF Hospitalization in Patients With Severe FMR
JACC: Cardiovascular Interventions
2022 - Characterization of the Average Daily Ischemic and Bleeding Risk After Primary PCI for STEMI
Journal of the American College of Cardiology
2017 - Survival After Varying Revascularization Strategies in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease
JACC: Cardiovascular Interventions
2016 - Impact of Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention on Short- and Long-Term Outcomes
Circulation Cardiovascular Interventions
2015 - Effect of Ischemia Duration and Door-to-Balloon Time on Myocardial Perfusion in ST-Segment Elevation Myocardial Infarction
JACC: Cardiovascular Interventions
2015
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”